celiprolol has been researched along with Hypercholesterolemia in 2 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
Excerpt | Relevance | Reference |
---|---|---|
"It can be concluded that subjects with moderate hypercholesterolemia and hypertension benefit more from lipid-lowering treatment with simvastatin than from blood pressure-lowering with beta blocker celiprolol." | 9.12 | Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study). ( Kalliomäki, T; Makkonen, N; Olkinuora, JT; Vanhanen, H; Viikari, J, 2006) |
"It can be concluded that subjects with moderate hypercholesterolemia and hypertension benefit more from lipid-lowering treatment with simvastatin than from blood pressure-lowering with beta blocker celiprolol." | 5.12 | Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study). ( Kalliomäki, T; Makkonen, N; Olkinuora, JT; Vanhanen, H; Viikari, J, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Olkinuora, JT | 1 |
Viikari, J | 1 |
Vanhanen, H | 1 |
Makkonen, N | 1 |
Kalliomäki, T | 1 |
Fogari, R | 1 |
Zoppi, A | 1 |
Corradi, L | 1 |
Preti, P | 1 |
Mugellini, A | 1 |
Lusardi, P | 1 |
2 trials available for celiprolol and Hypercholesterolemia
Article | Year |
---|---|
Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study).
Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Celiprolol; Coronary Disease; Drug Therapy, | 2006 |
Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atenolol; Bisopr | 1999 |